Home/Pipeline/Stelara (ustekinumab)

Stelara (ustekinumab)

Psoriasis, Crohn's Disease, Ulcerative Colitis

ApprovedCommercial

Key Facts

Indication
Psoriasis, Crohn's Disease, Ulcerative Colitis
Phase
Approved
Status
Commercial
Company

About Johnson & Johnson

Founded in 1886, Johnson & Johnson operates as a multinational healthcare corporation headquartered in New Brunswick, New Jersey. The company's pharmaceutical division, Janssen, is a global leader in oncology, immunology, and neuroscience with blockbuster drugs like Stelara, Darzalex, and Remicade. J&J combines deep scientific expertise with extensive global reach, serving patients in over 175 countries while maintaining one of the industry's strongest R&D pipelines.

View full company profile